Psychedelics policy came sharply into focus in 2023, with advocates chalking multiple wins as the drug policy reform movement’s momentum continued to expand beyond marijuana at the local, state and federal levels. It was a year defined by firsts: historic federal legislation signed into law mandating psychedelics clinical trials, first-ever Food and Drug Administration (FDA) … Continue reading The Psychedelics Reform Movement Accelerated In 2023, With New State Laws And Momentum At The Federal Level